Elos Medtech builds up a strong platform within Dental Implant Systems
Elos Medtech announces that Soren Olesen, Managing Director of Elos Medtech Pinol, will take up a new role as Dental Business Director and lead our global dental implant strategy within one of our important business segments, Dental Implant System.
During the years Elos Medtech has evolved a strong global dental offering as development- and manufacturing partner. Specialized expertise within development and manufacturing as well as innovative developed dental instruments and digital dentistry products, is the platform for Elos Medtech’s dental strategy and future growth. Elos Medtech has carefully invested in resources, capacity and implemented automation and robotics to support the strong demand from its customers on the dental market. Since 2014 Elos Medtech has proved a continuous strong double-digit growth (average +13%) in the Dental Implant System segment.
“Our long-term dedicated focus within this business segment is successful and creates new inquiries”, says Jan Wahlström, CEO and President. Leading dental players have chosen Elos Medtech as their key partner endorsing and confirming Elos Medtech’s role on the global dental implant market as their trusted strategic partner within development and production. I am pleased that Soren Olesen will lead our growth strategy within the strategic important business segment Dental Implant Systems.
“The outlook for 2018 and the coming years are positive. We plan to make significant investments to meet our customers increasing demand”, says Soren Olesen, Managing Director of Elos Medtech Pinol. “We are ready to take the next steps and embrace the US market with our dental products”. Soren Olesen will remain in Denmark and continue as the Managing Director of Elos Medtech Pinol.
Elos Medtech is one of the leading development and production partners for medical technology products and components in the world, such as dental and orthopedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and the US. Customers are internationally active medical technology companies.
Elos Medtech employs more than 500 people worldwide and generates revenue that exceeds MSEK 550. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.
Gothenburg, February 15, 2018
Elos Medtech AB (publ)
For further information, please contact: Jan Wahlström, CEO, +46 70 212 18 89, jan.wahlstrom@elosmedtech.com Soren Olesen, Managing Director Elos Medtech Pinol,+45 40 41 28 82, soren.olesen@elosmedtech.com
For additional information about the Elos Medtech Group, visit www.elosmedtech.com
This information is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on February 15, 2018, at 08:00 (CET).
Tags: